About Fingerprint Drug Testing

A smarter way to screen for recent drug use

Our Fingerprint Drug Testing Programme exists to solve a real operational problem: how to carry out effective drug screening without unnecessary disruption, discomfort or delay.

As a result, it provides a modern, non-invasive alternative that works in real-world environments. Furthermore, the system supports timely fitness-for-duty decisions while maintaining dignity, auditability and compliance.

A Modern Alternative to Traditional Drug Testing

Traditional testing methods can be slow, intrusive and logistically difficult — particularly during site inductions, random testing or mobile operations.

Our Fingerprint Drug Testing Programme is delivered by Auctus Management Group, an established provider of safety-critical services across UK infrastructure.

Delivered by Auctus Management Group

Auctus Management Group (AMG), delivers the Fingerprint Drug Testing Programme, an established provider of safety-critical services across UK infrastructure, with extensive experience operating in regulated rail and light rail environments.

AMG has extensive experience operating in regulated rail and light rail environments. Consequently, our sector knowledge informs how FDT is deployed — with clear governance, defensible processes and practical support to ensure it works safely and consistently in real-world operations.

The Principles Behind Our Fingerprint Drug Testing Programme

Above all, technology must support real operations, not add complexity or risk, ensuring drug screening strengthens safety, efficiency and decision-making in demanding, safety-critical environments.

In addition, innovation should be responsible, evidence-led and compliant. As a result, organisations must deliver drug screening that is effective, proportionate and respectful, protecting workforce dignity while delivering reliable, auditable results organisations can stand behind.

Our Fingerprint Drug Testing programme improves safety and efficiency by delivering fast, dignified screening that works in real-world, safety-critical environments.

Richard Toy

CEO & Co-Founder